Bicycle Therapeutics PLC
NASDAQ:BCYC
Bicycle Therapeutics PLC
NASDAQ:BCYC
Price:
4.34
USD
-0.23%
Market Closed
Market Cap:
$301.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
UK |
|
Comptoir Group PLC
LSE:COM
|
UK |
|
L
|
LGMS Bhd
KLSE:LGMS
|
MY |
|
Integrated Diagnostics Holdings PLC
LSE:IDHC
|
JE |
|
Asante Inc
TSE:6073
|
JP |
|
E
|
Everest Medicines Ltd
HKEX:1952
|
CN |
|
Mutoh Holdings Co Ltd
TSE:7999
|
JP |
|
Hemlo Explorers Inc
XTSX:HMLO
|
CA |
|
Dixon Technologies (India) Ltd
BSE:540699
|
IN |
|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
CN |
Relative Value
The Relative Value of one
BCYC
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 4.34 USD,
Bicycle Therapeutics PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BCYC Relative Value
HIDDEN
Multiples Across Competitors
BCYC Competitors Multiples
Bicycle Therapeutics PLC Competitors
Bicycle Therapeutics PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
300.8m USD | 10.6 | -1.2 | 1.2 | 1.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD | 5.9 | 86.5 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.6B USD | 9.5 | 29 | 21.8 | 22.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.4B AUD | 3.1 | 34.2 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.6B USD | 10.9 | 129.6 | 72.5 | 80.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
